Pharma giants Pfizer and Moderna just secured multi-billion dollar deals to supply the US government with more than 170 million…
McAlinden Research PartnersAugust 1, 2022
Unsurprisingly, Russia has once again cut the amount of gas headed for Europe via the Nord Stream 1 pipeline. With…
McAlinden Research PartnersJuly 27, 2022
The Biden Administration is prepping the US's latest wave of military assistance to Ukraine in their defensive struggle against the Russian invasion.…
McAlinden Research PartnersJuly 26, 2022
New talent is increasingly hard to come by in high profile sectors of Hong Kong's economy - particularly the all-important…
McAlinden Research PartnersJuly 25, 2022
The number of cyberattacks are on the rise, but the average cost of each attack is increasing even faster. Billions of…
McAlinden Research PartnersJuly 22, 2022
Despite a drawdown in the share prices of data center REITs, spending on facilities is booming this year. Several key…
McAlinden Research PartnersJuly 20, 2022
US banks' second quarter results helped to map out an uncertain future for the financial sector. Trading revenues rose but…
McAlinden Research PartnersJuly 19, 2022
Psychedelic medicine, focused on alternative mental health therapies that utilize drugs like LSD, MDMA and psilocybin, is becoming increasingly popular…
McAlinden Research PartnersJuly 18, 2022
Last year marked one of the least active years for biopharma merger and acquisition (M&A) activity in a decade. The first…
McAlinden Research PartnersJuly 14, 2022
